Speech-Language Pathologists in North Providence, RI Accepting Medicare

6 Speech-Language Pathologists found. Showing 1 - 6

Mr. Thomas Matthew Landry, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 40 Ambrose St, North Providence, RI 02904 Phone: 401-419-9284

Laurarose Gauvin, MS, CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 610 Smithfield Rd, North Providence, RI 02904 Phone: 401-353-6300

Melissa Simonian Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5 River Rd, North Providence, RI 02904 Phone: 401-353-9527

Alyssa Piampiano, SLP-CF Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 610 Smithfield Rd, North Providence, RI 02904 Phone: 401-353-6300

Alison Whitty Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 610 Smithfield Rd, North Providence, RI 02904 Phone: 401-353-6300

Ms. Patricia Bellini, M.S. CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 24 Forest View Dr, North Providence, RI 02904 Phone: 401-353-7893

News Archive

Ingen reports 1,200% increase in sales for fiscal 2010

Ingen Technologies, Inc., an emerging medical device manufacturer developing innovative solutions for the respiratory market, with a new patented and proprietary medical product line targeting the $8 billion respiratory market, today announced that its Annual Report has been filed with the OTC Markets, while auditors have completed and filed required restatements needed to return to "fully reporting" status.

NIAID-funded study to evaluate PPSV23 and PCV13 in Phase Iib pneumococcal trial

Researchers plan to see if a higher dose of a pneumococcal vaccine will create a stronger immune response in older adults who received an earlier generation vaccine against pneumonia and other pneumococcal diseases.

World Alzheimer's Day 2019: A timely reminder of urgent need for new drugs to tackle disease

As World Alzheimer's Day 2019 approaches (21 September), with the aim this year of raising global awareness and understanding of the stigma, stereotypes and myths that surround a dementia diagnosis;

Rigel Pharmaceuticals receives 2010 Innovators Award of Excellence

Rigel Pharmaceuticals, Inc. has been named one of the recipients of the 2010 Innovators Award of Excellence by the San Mateo County Economic Development Association. The award will be presented at the association's Innovators luncheon today at the Oracle Conference Center in Redwood City.

Alnylam, Precision NanoSystems enter collaboration for discovery of novel small lipid nanoparticles

Precision NanoSystems, Inc. and Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the two companies have formed an exclusive collaboration focused on the discovery and development of novel lipid nanoparticles, known as small lipid nanoparticles ("sLNPs"), using microfluidics technology.

Read more Medical News

› Verified 3 days ago